This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
In a time where the demand for digital health technologies is needed, the Digital Health Collaborative, a new organization dedicated to advancing the evidence and adoption of digital health solutions, has gained support from 14 leading healthcare and consumer organizations.
© stock.adobe.com
Despite advancements in this space, purchasers are challenged with determining the best solutions for their digital health needs.
This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
The Peterson Health Technology Institute (PHTI), an initiative of the Peterson Center on Healthcare, is a supporter of the Collaborative.
PHTI assesses digital health solutions to determine their clinical effectiveness and financial impact for purchasers like payers, providers, and employers on behalf of patients.
Meg Baron, managing director of engagement and outreach at PHTI shared with Managed Healthcare Executive, "Collaborative members will jointly work together on research, programs, and knowledge sharing to help raise purchaser confidence and adoption of digital health solutions. Initial activities will include a national survey of digital health purchasers, grantmaking through a Research and Impact Fund, and regular convenings, including at an annual Summit."
Collaborative members include:
Through support from PHTI, the Collaborative will offer the Research and Impact Fund for aligned research and programs.
The first grant was awarded to DiMe for its Integrated Evidence Plans for Digital Health Products project to help developers align digital health products with purchaser evidence requirements.
“With a growing market of digital health solutions available to providers and consumers, the Digital Health Collaborative will play an important role in helping to bring together the perspectives and voices across the health system to meaningfully share insights on new and emerging technology,” Danielle Lloyd, senior vice president of Private Market Innovations and Quality at AHIP, said. “We hope the Collaborative’s research, analysis and data initiatives can help fill important gaps in assessing clinical value and health outcomes for stakeholders across the health system.”
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes in Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Experts Explore Causes and Care for Chronic Itch
April 22nd 2025In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., Brian Kim, M.D., and Gil Yosipovitch, M.D.—shared where the science is going, what’s holding it back and how the healthcare system can better support patients.
Read More